BioCentury
ARTICLE | Company News

Acambis, Novartis, Centers for Disease Control and Prevention infectious news

September 18, 2006 7:00 AM UTC

ACM said the CDC agreed to purchase an additional 10 million doses of the company's ACAM2000 smallpox vaccine under an existing supply contract. ACM said the new order is worth about $30 million. Under the contract, ACM already has produced and delivered 182.5 million doses for the U.S.'s Strategic National Stockpile (see BioCentury, Sep. 1, 2003). A BLA for ACAM2000 is under FDA review with a Feb. 14, 2007, PDUFA date. ...